ISTR:NASDAQInvestar Holding Corporation Analysis
Data as of 2026-06-12 - not real-time
$29.78
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Investar Holding is trading at $29.78, comfortably above its 20‑day SMA of $28.52 and the 50‑day SMA, confirming a bullish price bias. Technical momentum is reinforced by a bullish MACD crossover and a RSI of 67, suggesting the stock is approaching overbought territory but still has room to run. The 30‑day volatility of roughly 18½% and a beta of 0.82 indicate moderate price swings with less market‑wide risk than the broader index. Fundamentally, the company posted a striking 57.6% revenue surge and maintains a 44% operating margin, delivering a solid 26.7% profit margin. At a trailing P/E of 13.1 versus the industry average of 16.6, and a forward P/E near 9.1, the valuation appears attractive, especially given the DCF‑derived fair value of $34.4, implying roughly 11% upside. The dividend yield of 1.48% with a modest 19% payout ratio underscores sustainability, while recent shareholder approval of the director slate and incentive plan adds governance confidence.
The balance sheet shows cash of $90.9 M against debt of $209 M, and the firm’s market cap of $410 M provides sufficient liquidity, though trading volumes are modestly improving. With a strong earnings outlook, a dividend that can be comfortably covered, and a valuation gap to intrinsic value, the stock is positioned for medium‑ to long‑term appreciation, while short‑term traders should watch the nearby resistance at $29.88 and the elevated RSI for potential profit‑taking pressure.
The balance sheet shows cash of $90.9 M against debt of $209 M, and the firm’s market cap of $410 M provides sufficient liquidity, though trading volumes are modestly improving. With a strong earnings outlook, a dividend that can be comfortably covered, and a valuation gap to intrinsic value, the stock is positioned for medium‑ to long‑term appreciation, while short‑term traders should watch the nearby resistance at $29.88 and the elevated RSI for potential profit‑taking pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance level of $29.88
- Elevated RSI indicating potential short‑term pullback
- Bullish MACD confirming underlying momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF fair value and industry P/E
- Robust revenue growth and high operating margins
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent earnings expansion and strong cash generation
- Low beta and moderate volatility supporting defensive profile
- Positive governance outcomes and dividend continuity
Key Metrics & Analysis
Financial Health
Revenue Growth57.60%
Profit Margin26.73%
P/E Ratio13.1
ROE8.59%
ROA0.87%
P/B Ratio1.1
Op. Cash Flow$23.7M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI67.3
Support$27.52
Resistance$29.88
MA 20$28.52
MA 50$28.29
MA 200$26.36
MACDBullish
VolumeIncreasing
Fear & Greed Index88.2
Valuation
Fair Value$34.37
Target Price$33.00
Upside/Downside10.81%
GradeUndervalued
TypeBlend
Dividend Yield1.48%
Risk Assessment
Beta0.82
Volatility18.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.